GNRH1 and tetanus: Such studies have involved either passive immunization by infusion of anti-LHRH antibodies (14) or vaccination with the LHRH peptide coupled to tetanus or Diphtheria toxoid (DT) molecules as carriers (11–14), or LHRH in multiple antigen peptide (MAP) constructs (15).